227 related articles for article (PubMed ID: 22349104)
1. Alpha-1 antitrypsin: a potent anti-inflammatory and potential novel therapeutic agent.
Bergin DA; Hurley K; McElvaney NG; Reeves EP
Arch Immunol Ther Exp (Warsz); 2012 Apr; 60(2):81-97. PubMed ID: 22349104
[TBL] [Abstract][Full Text] [Related]
2. alpha1-Antitrypsin deficiency: best clinical practice.
Kalsheker NA
J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
4. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
5. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 antitrypsin augmentation therapy.
Wewers MD; Crystal RG
COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
[TBL] [Abstract][Full Text] [Related]
7. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
8. α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8.
Bergin DA; Reeves EP; Meleady P; Henry M; McElvaney OJ; Carroll TP; Condron C; Chotirmall SH; Clynes M; O'Neill SJ; McElvaney NG
J Clin Invest; 2010 Dec; 120(12):4236-50. PubMed ID: 21060150
[TBL] [Abstract][Full Text] [Related]
9. Sharing a precious resource: an example of the promise of therapeutics for rare diseases to treat common conditions.
Walsh JW; Campber R
COPD; 2012 Dec; 9(6):581-2. PubMed ID: 23244168
[No Abstract] [Full Text] [Related]
10. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil elastase-mediated lung disease.
Sandhaus RA; Turino G
COPD; 2013 Mar; 10 Suppl 1():60-3. PubMed ID: 23527919
[TBL] [Abstract][Full Text] [Related]
12. Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency.
Tirado-Conde G; Lara B; Miravitlles M
Ther Adv Respir Dis; 2008 Feb; 2(1):13-21. PubMed ID: 19124355
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice.
Ostermann L; Maus R; Stolper J; Schütte L; Katsarou K; Tumpara S; Pich A; Mueller C; Janciauskiene S; Welte T; Maus UA
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554955
[TBL] [Abstract][Full Text] [Related]
14. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.
Tonelli AR; Brantly ML
Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).
Lior Y; Geyra A; Lewis EC
Expert Opin Ther Pat; 2016 May; 26(5):581-9. PubMed ID: 26966859
[TBL] [Abstract][Full Text] [Related]
16. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
Louie SG; Sclar DA; Gill MA
Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
[TBL] [Abstract][Full Text] [Related]
17. Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.
Cosio MG; Bazzan E; Rigobello C; Tinè M; Turato G; Baraldo S; Saetta M
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S305-10. PubMed ID: 27564665
[TBL] [Abstract][Full Text] [Related]
18. A review of alpha-1 antitrypsin deficiency.
Ioachimescu OC; Stoller JK
COPD; 2005 Jun; 2(2):263-75. PubMed ID: 17136953
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1 antitrypsin deficiency: new developments in augmentation and other therapies.
Turner AM
BioDrugs; 2013 Dec; 27(6):547-58. PubMed ID: 23771682
[TBL] [Abstract][Full Text] [Related]
20. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
